Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation.
Saved in:
| Title: | Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation. |
|---|---|
| Authors: | Peters S; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. Electronic address: https://twitter.com/peters_solange., Meyer ML; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland., André F; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Université Paris-Saclay, Villejuif, France., Argilés G; Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Azizi AA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. Electronic address: https://twitter.com/Alex_Azizi_., Banerjee S; Gynaecology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK., Burgers S; Department of Thoracic Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Curigliano G; Division of Early Drug Development, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: https://twitter.com/curijoey., Drago JZ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: https://twitter.com/joshdragomd., Fontana E; Drug Development Unit, Sarah Cannon Research Institute, London, UK., Garon EB; David Geffen School of Medicine, University of California, Los Angeles, USA., Klümper N; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn; Department of Urology, University Hospital Bonn (UKB), Bonn, Germany; Institute of Experimental Oncology, University Hospital Bonn (UKB), Bonn, Germany. Electronic address: https://twitter.com/niklas_kluemper., Le Bescond L; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France; Molecular Predictors and New Targets in Oncology, INSERM U981, Gustave Roussy, Villejuif, France; Centre for Visual Computing, CentraleSupélec, Inria, Université Paris-Saclay, Gif-Sur-Yvette, France., Lopez-Rios F; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Mountzios G; 4th Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece. Electronic address: https://twitter.com/g_mountzios., Passaro A; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: https://twitter.com/APassaroMD., Paz-Ares L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. Electronic address: https://twitter.com/lpazares., Pistilli B; Department of Medical Oncology, Gustave Roussy, Villejuif, France; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France. Electronic address: https://twitter.com/BarbaraPistill2., Powles T; Barts Cancer Institute, National Institute for Health Research Biomedical Research Centre, Queen Mary University of London, London, UK. Electronic address: https://twitter.com/etop_ibcsg., Reguart N; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. Electronic address: https://twitter.com/nreguart., Remon J; Department of Cancer Medicine, Gustave Roussy, Villejuif, France., Schmelzle T; Novartis Biomedical Research, Basel, Switzerland., Skynner MJ; Bicycle Therapeutics Ltd, Cambridge, UK., Smit E; Department of Pulmonary Diseases, Leiden University Medical Center, Leiden, The Netherlands., Smyth E; NIHR Biomedical Research Centre, Oxford, UK. Electronic address: https://twitter.com/lizzysmyth1., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Oncology, University College London Hospitals, London, UK., Van Cutsem E; Department of Digestive Oncology, University Hospital Gasthuisberg and University of Leuven (KUL), Leuven, Belgium., Loi S; Department of Cancer Research, Peter MacCallum Cancer Center, Melbourne, Australia; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia., Stahel RA; Coordinating Center, ETOP IBCSG Partners Foundation, Bern, Switzerland. Electronic address: rolf.stahel@etop.ibcsg.org. |
| Source: | ESMO open [ESMO Open] 2026 Jul 10; Vol. 11 (8), pp. 108316. Date of Electronic Publication: 2026 Jul 10. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier Country of Publication: England NLM ID: 101690685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2059-7029 (Electronic) Linking ISSN: 20597029 NLM ISO Abbreviation: ESMO Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42431135 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Peters+S%22">Peters S</searchLink>; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland. Electronic address: https://twitter.com/peters&#95;solange.<br /><searchLink fieldCode="AU" term="%22Meyer+ML%22">Meyer ML</searchLink>; Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22André+F%22">André F</searchLink>; Department of Medical Oncology, Gustave Roussy, Villejuif, France; Université Paris-Saclay, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Argilés+G%22">Argilés G</searchLink>; Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.<br /><searchLink fieldCode="AU" term="%22Azizi+AA%22">Azizi AA</searchLink>; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. Electronic address: https://twitter.com/Alex&#95;Azizi&#95;.<br /><searchLink fieldCode="AU" term="%22Banerjee+S%22">Banerjee S</searchLink>; Gynaecology Unit, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK.<br /><searchLink fieldCode="AU" term="%22Burgers+S%22">Burgers S</searchLink>; Department of Thoracic Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Curigliano+G%22">Curigliano G</searchLink>; Division of Early Drug Development, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. Electronic address: https://twitter.com/curijoey.<br /><searchLink fieldCode="AU" term="%22Drago+JZ%22">Drago JZ</searchLink>; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address: https://twitter.com/joshdragomd.<br /><searchLink fieldCode="AU" term="%22Fontana+E%22">Fontana E</searchLink>; Drug Development Unit, Sarah Cannon Research Institute, London, UK.<br /><searchLink fieldCode="AU" term="%22Garon+EB%22">Garon EB</searchLink>; David Geffen School of Medicine, University of California, Los Angeles, USA.<br /><searchLink fieldCode="AU" term="%22Klümper+N%22">Klümper N</searchLink>; Center for Integrated Oncology Aachen/Bonn/Cologne/Düsseldorf (CIO-ABCD), Bonn; Department of Urology, University Hospital Bonn (UKB), Bonn, Germany; Institute of Experimental Oncology, University Hospital Bonn (UKB), Bonn, Germany. Electronic address: https://twitter.com/niklas&#95;kluemper.<br /><searchLink fieldCode="AU" term="%22Le+Bescond+L%22">Le Bescond L</searchLink>; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France; Molecular Predictors and New Targets in Oncology, INSERM U981, Gustave Roussy, Villejuif, France; Centre for Visual Computing, CentraleSupélec, Inria, Université Paris-Saclay, Gif-Sur-Yvette, France.<br /><searchLink fieldCode="AU" term="%22Lopez-Rios+F%22">Lopez-Rios F</searchLink>; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Mountzios+G%22">Mountzios G</searchLink>; 4th Department of Medical Oncology and Clinical Trials Unit, Henry Dunant Hospital Center, Athens, Greece. Electronic address: https://twitter.com/g&#95;mountzios.<br /><searchLink fieldCode="AU" term="%22Passaro+A%22">Passaro A</searchLink>; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan, Italy. Electronic address: https://twitter.com/APassaroMD.<br /><searchLink fieldCode="AU" term="%22Paz-Ares+L%22">Paz-Ares L</searchLink>; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain. Electronic address: https://twitter.com/lpazares.<br /><searchLink fieldCode="AU" term="%22Pistilli+B%22">Pistilli B</searchLink>; Department of Medical Oncology, Gustave Roussy, Villejuif, France; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France. Electronic address: https://twitter.com/BarbaraPistill2.<br /><searchLink fieldCode="AU" term="%22Powles+T%22">Powles T</searchLink>; Barts Cancer Institute, National Institute for Health Research Biomedical Research Centre, Queen Mary University of London, London, UK. Electronic address: https://twitter.com/etop&#95;ibcsg.<br /><searchLink fieldCode="AU" term="%22Reguart+N%22">Reguart N</searchLink>; Department of Medical Oncology, Hospital Clínic de Barcelona, Barcelona, Spain. Electronic address: https://twitter.com/nreguart.<br /><searchLink fieldCode="AU" term="%22Remon+J%22">Remon J</searchLink>; Department of Cancer Medicine, Gustave Roussy, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Schmelzle+T%22">Schmelzle T</searchLink>; Novartis Biomedical Research, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Skynner+MJ%22">Skynner MJ</searchLink>; Bicycle Therapeutics Ltd, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Smit+E%22">Smit E</searchLink>; Department of Pulmonary Diseases, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Smyth+E%22">Smyth E</searchLink>; NIHR Biomedical Research Centre, Oxford, UK. Electronic address: https://twitter.com/lizzysmyth1.<br /><searchLink fieldCode="AU" term="%22Swanton+C%22">Swanton C</searchLink>; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK; Department of Oncology, University College London Hospitals, London, UK.<br /><searchLink fieldCode="AU" term="%22Van+Cutsem+E%22">Van Cutsem E</searchLink>; Department of Digestive Oncology, University Hospital Gasthuisberg and University of Leuven (KUL), Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Loi+S%22">Loi S</searchLink>; Department of Cancer Research, Peter MacCallum Cancer Center, Melbourne, Australia; Department of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Australia; The Sir Peter MacCallum Department of Medical Oncology, The University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Stahel+RA%22">Stahel RA</searchLink>; Coordinating Center, ETOP IBCSG Partners Foundation, Bern, Switzerland. Electronic address: rolf.stahel@etop.ibcsg.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101690685%22">ESMO open</searchLink> [ESMO Open] 2026 Jul 10; Vol. 11 (8), pp. 108316. <i>Date of Electronic Publication: </i>2026 Jul 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101690685 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2059-7029 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220597029%22">20597029 </searchLink><i>NLM ISO Abbreviation: </i>ESMO Open <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42431135 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.esmoop.2026.108316 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 108316 Titles: – TitleFull: Antibody-drug conjugates in selected solid tumours: a position statement update based on findings from the third workshop held by the ETOP IBCSG Partners Foundation. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Peters S – PersonEntity: Name: NameFull: Meyer ML – PersonEntity: Name: NameFull: André F – PersonEntity: Name: NameFull: Argilés G – PersonEntity: Name: NameFull: Azizi AA – PersonEntity: Name: NameFull: Banerjee S – PersonEntity: Name: NameFull: Burgers S – PersonEntity: Name: NameFull: Curigliano G – PersonEntity: Name: NameFull: Drago JZ – PersonEntity: Name: NameFull: Fontana E – PersonEntity: Name: NameFull: Garon EB – PersonEntity: Name: NameFull: Klümper N – PersonEntity: Name: NameFull: Le Bescond L – PersonEntity: Name: NameFull: Lopez-Rios F – PersonEntity: Name: NameFull: Mountzios G – PersonEntity: Name: NameFull: Passaro A – PersonEntity: Name: NameFull: Paz-Ares L – PersonEntity: Name: NameFull: Pistilli B – PersonEntity: Name: NameFull: Powles T – PersonEntity: Name: NameFull: Reguart N – PersonEntity: Name: NameFull: Remon J – PersonEntity: Name: NameFull: Schmelzle T – PersonEntity: Name: NameFull: Skynner MJ – PersonEntity: Name: NameFull: Smit E – PersonEntity: Name: NameFull: Smyth E – PersonEntity: Name: NameFull: Swanton C – PersonEntity: Name: NameFull: Van Cutsem E – PersonEntity: Name: NameFull: Loi S – PersonEntity: Name: NameFull: Stahel RA IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 07 Text: 2026 Jul 10 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2059-7029 Numbering: – Type: volume Value: 11 – Type: issue Value: 8 Titles: – TitleFull: ESMO open Type: main |
| ResultId | 1 |